Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

BackgroundNon–small cell lung cancer (NSCLC) has entered the era of immunotherapy. However, only partial patients were able to benefit from immune checkpoint inhibitors (ICIs). Currently, biomarkers for predicting patients’ response to ICIs are primarily tumor tissue dependent and have limited accur...

詳細記述

書誌詳細

主要な著者:	Kang Miao, Xiaotong Zhang, Hanping Wang, Xiaoyan Si, Jun Ni, Wei Zhong, Jing Zhao, Yan Xu, Minjiang Chen, Ruili Pan, Mengzhao Wang, Li Zhang
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2022-07-01
シリーズ:	Frontiers in Immunology
主題:	immune checkpoint inhibitors (ICIs) lymphocyte subsets CD4+CD45RA− T cell biomarker CD8+CD38+ T cell
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.912180/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!